Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

RBC Bioscience Corporation (6848) Income Statement

RBC Bioscience Corporation Income Statement

Last quarter (Q2 2026), RBC Bioscience Corporation's total revenue was NT$108.59M, a decrease of 2.25% from the same quarter last year. In Q2, RBC Bioscience Corporation's net income was NT$8.68M. See RBC Bioscience Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 219.71MNT$ 205.25MNT$ 172.47MNT$ 173.89MNT$ 251.18M
NT$ 92.59MNT$ 98.07MNT$ 72.89MNT$ 73.01MNT$ 117.07M
NT$ 57.56MNT$ 62.27MNT$ 58.36MNT$ 65.35MNT$ 68.83M
Depreciation and AmortizationNT$ 16.09MNT$ 18.09MNT$ 19.20MNT$ 19.74MNT$ 19.86M
NT$ 51.12MNT$ 55.35MNT$ 37.07MNT$ 32.12MNT$ 62.31M
NT$ 35.03MNT$ 35.80MNT$ 14.54MNT$ 7.75MNT$ 48.61M
NT$ -5.23MNT$ -8.84MNT$ -6.67MNT$ -2.83MNT$ -12.66M
NT$ 29.80MNT$ 26.96MNT$ 7.87MNT$ 4.92MNT$ 35.95M
NT$ 23.54MNT$ 21.57MNT$ 6.43MNT$ 3.78MNT$ 28.73M
Per Share Metrics
Basic EPSNT$ 1.65NT$ 1.51NT$ 0.50NT$ 0.29NT$ 2.21
Diluted EPSNT$ 1.64NT$ 1.50NT$ 0.49NT$ 0.29NT$ 2.34
Weighted Average Shares Outstanding14.27M13.01M12.98M12.98M11.83M
Weighted Average Shares Outstanding (Diluted)14.38M13.06M13.00M13.01M12.30M

Currency in TWD

RBC Bioscience Corporation Earnings and Revenue History

0250M500M750M0 %10 %20 %30 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin